Locke Jayme E, Warren Daniel S, Singer Andrew L, Segev Dorry L, Simpkins Christopher E, Maley Warren R, Montgomery Robert A, Danovitch Gabriel, Cameron Andrew M
Department of Surgery, Division of Transplantation, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Transplantation. 2008 Apr 15;85(7):935-42. doi: 10.1097/TP.0b013e318168476d.
When the United Network for Organ Sharing changed its algorithm for liver allocation to the model for end-stage liver disease (MELD) system in 2002, highest priority shifted to patients with renal insufficiency as a major component of their end-stage liver disease. An unintended consequence of the new system was a rapid increase in the number of simultaneous liver-kidney transplants (SLK) being performed yearly.
Adult recipients of deceased donor liver transplants (LT, n=19,137), kidney transplants (n=33,712), and SLK transplants (n=1,032) between 1987 and 2006 were evaluated based on United Network for Organ Sharing data. Recipients were stratified by donor subgroup, MELD score, pre- versus post-MELD era, and length of time on dialysis. Matched-control analyses were performed, and graft and patient survival were analyzed by Kaplan-Meier and Cox proportional hazards analyses.
MELD era outcomes demonstrate a decline in patient survival after SLK. Using matched-control analysis, we are unable to demonstrate a benefit in the SLK cohort compared with LT, despite the fact that higher quality allografts are being used for SLK. Subgroup analysis of the SLK cohort did demonstrate an increase in overall 1-year patient and liver graft survival only in those patients on long-term dialysis (> or =3 months) compared with LT (84.5% vs. 70.8%, P=0.008; hazards ratio 0.57 [95% CI 0.34, 0.95], P=0.03).
These findings suggest that SLK may be overused in the MELD era and that current prioritization of kidney grafts to those liver failure patients results in wasting of limited resources.
2002年,美国器官共享联合网络将其肝脏分配算法改为终末期肝病模型(MELD)系统时,最高优先级转向了肾功能不全作为其终末期肝病主要组成部分的患者。新系统的一个意外后果是每年进行的同期肝肾联合移植(SLK)数量迅速增加。
基于美国器官共享联合网络的数据,对1987年至2006年间接受已故供体肝脏移植(LT,n = 19137)、肾脏移植(n = 33712)和SLK移植(n = 1032)的成年受者进行评估。受者按供体亚组、MELD评分、MELD时代前后以及透析时间长短进行分层。进行匹配对照分析,并通过Kaplan-Meier和Cox比例风险分析对移植物和患者生存率进行分析。
MELD时代的结果显示SLK后患者生存率下降。使用匹配对照分析,我们无法证明SLK队列与LT相比有优势,尽管事实上更高质量的同种异体移植物被用于SLK。SLK队列的亚组分析确实表明,与LT相比,仅长期透析(≥3个月)的患者的1年总体患者和肝脏移植物生存率有所提高(84.5%对70.8%,P = 0.008;风险比0.57 [95% CI 0.34, 0.95],P = 0.03)。
这些发现表明,在MELD时代,SLK可能被过度使用,并且目前将肾移植优先分配给那些肝衰竭患者会导致有限资源的浪费。